The Palo Alto Medical Foundation is one of seven physician organizations in the Sutter Health network of care that received recognition today as a quality performer in medical care from the Integrated Healthcare Association (IHA), a renowned industry leadership group in California. With today’s recognition, the Palo Alto Medical Foundation became the only IHA-recognized physician organization to receive the quality performer recognition every year since 2003. Read More about PAMF Earns Quality Performer Award
The Palo Alto Medical Foundation (PAMF) was one of six physician organizations in the Sutter Medical Network to receive “Elite” honors from the California Association of Physician Groups’ (CAPG) Standards of Excellence Survey—the highest recognition awarded by the professional organization.
Winners in the Sutter Health Network include the following:
Elite Status (4 stars / highest recognition)
- Brown & Toland Physicians
- Palo Alto Medical Foundation
- Sutter East Bay Medical Foundation
- Sutter Gould Medical Foundation
- Sutter Medical Foundation
- Sutter Pacific Medical Foundation
Sent each year to dozens of participating physician organizations throughout California, the survey provides a thorough examination of the tools and processes CAPG members have in place to meet the escalating expectations of health care purchasers and patients. It helps set the bar for consumers to evaluate a physician group’s technical quality, patient experience and affordability.
“Recognitions such as these are among the most meaningful because they acknowledge the commitment of our network’s doctors and care teams to providing patients with an exceptional, personal and consistent experience,” said Sutter Medical Network Senior Vice President and Executive Officer Jeff Burnich.
Physician organizations voluntarily participate in CAPG’s Standards of Excellence survey. This year 62 organizations, collectively caring for 11.1 million Californians, voluntarily participated in the survey.
About the Palo Alto Medical Foundation
The Palo Alto Medical Foundation (PAMF) for Health Care, Research and Education, is part of the Sutter Health network of care. Founded in 1930, PAMF is a not-for-profit health care organization that is a pioneer in the multispecialty group practice of medicine, health innovation and patient-centered care. PAMF’s more than 1,200 affiliated physicians and 5,400 employees serve nearly 850,000 patients at its medical centers and clinics in Alameda, San Mateo, Santa Clara and Santa Cruz counties. The Palo Alto Medical Foundation is part of Sutter Health’s Peninsula Coastal Region, which also includes Mills-Peninsula Medical Center, Sutter Maternity & Surgery Center and Menlo Park Surgical Hospital. For more information about the Palo Alto Medical Foundation, please visit the PAMF website and blog, follow us on Twitter, and join us on Facebook and Google+. To learn about PAMF’s Druker Center for Health Systems Innovation, visit the PAMF Innovation Center website.
About Sutter Health
Serving patients and their families in more than 100 Northern California cities and towns, Sutter Health doctors, not-for-profit hospitals and other health care service providers share resources and expertise to advance health care quality and access. The Sutter Medical Network includes many of California’s top-performing, highest quality physician organizations as measured annually by the Integrated Healthcare Association. Sutter-affiliated hospitals are regional leaders in cardiac care, women’s and children’s services, cancer care, orthopedics and advanced patient safety technology.
PAMF, El Camino Hospital Provide Minimally Invasive Procedures, More Comprehensive Care in Silicon Valley
The Palo Alto Medical Foundation and El Camino Hospital announced today an expansion of the hospital’s Neuroscience Institute to now include neurointerventional services. Patients at the hospital’s Mountain View campus can now receive treatment for a wider range of diseases of the brain and spine and enhanced offerings for stroke-related care, neuro-oncology and neuro-critical care and comprehensive spine care.
To provide patients with the greatest breadth of expertise, this partnership brings together El Camino Hospital’s clinical expertise with that of Palo Alto Medical Foundation and independent physicians to benefit patients and families across the Silicon Valley area.
Program is one of only 15 nationwide to offer innovative, minimally invasive treatment options for complex pulmonary diseases
El Camino Hospital and Palo Alto Medical Foundation are collaborating with the University of California, San Francisco (UCSF) Fellowship Program to be the first West Coast sites to offer interventional pulmonology fellowships for pulmonary fellows.
Interventional pulmonology (IP) is an emerging field within pulmonary medicine that focuses on the use of advanced diagnostic and therapeutic techniques to treat patients with lung cancer, airway disorders and pleural (lung) diseases.
Ganesh Krishna, M.D., an interventional pulmonologist at Palo Alto Medical Foundation and El Camino Hospital, is the chair of the fellowship search and director of the fellowship program. The joint IP program is the leading program on the West Coast and one of only 15 nationwide providing diagnostic and therapeutic services and cutting-edge treatment in pulmonary medicine.
Generous Support Enhances Pediatric Vision Services for the Underserved and Anchors Capital Campaign for new Sunnyvale Vision Care Center
The Sunnyvale Vision Care Center of the Palo Alto Medical Foundation (PAMF) has received an $800,000 gift from Charles R. Munnerlyn, Ph.D., and Judith Munnerlyn. The contribution will support two important vision initiatives at PAMF. First, it will provide free vision care to underserved children as part of a partnership with the Sunnyvale School District. Second, the donation launches a $1.2 million capital campaign to begin building PAMF’s Sunnyvale Vision Care Center. Scheduled to open in the second half of 2016, the vision care center will named the Munnerlyn Eye Institute.
“I’ve spent my entire career developing innovative ophthalmic instruments from automated refractors to glaucoma testing equipment to lasers for treating eye diseases, and, ultimately, a laser for vision correction,” said Dr. Munnerlyn, who received his Ph.D. in optical engineering. “Nothing is more rewarding than having people tell me how they benefitted from vision technologies with which I have been involved. Making a contribution like this to Sunnyvale and the surrounding communities, provides a means not only for testing the vision of young people, but building the Eye Institute gives more people access to eye care and expands existing services.”
Dr. Munnerlyn is known as one of the founding fathers of laser vision correction for his role in developing the technology which has been used on more than 15 million eyes. In the 1970s, Dr. Munnerlyn founded VISX, Incorporated, which became the leading manufacturer of laser-based vision correction systems in the world. He serves on the board of the Foundation of the American Academy of Ophthalmology.